Measurement of free carnitine and acylcarnitines allows the detection of several inborn errors of metabolism in neonatal screening. Because available data for premature infants is limited, we studied longitudinal changes in acylcarnitine profiles of full-term and preterm neonates over the first 4 weeks of life. One hundred twenty infants were divided into four groups of 30: A, gestational age 22 to 27 wk; B, 28 to 31 wk; C, 32 to 36 wk; and D, 37 to 41 wk. Blood samples spotted on a Guthrie card were taken on days 5 and 28. Additional specimens (groups A and B only) were collected on days 1, 3, 7, and 14. Carnitine and its acyl esters were detected by looking for the precursor ions of m/z ϭ 85 using a PE Sciex API 365 electrospray ionization tandem mass spectrometer. Concentrations of free carnitine and most acylcarnitines were significantly higher in group A compared with group D postnatally. Groups B and C displayed intermediate values. Carnitine levels in infants from group A and B decreased steadily from day 1 to day 7, and recovered up to day 14 in group B only. On day 28 carnitine concentrations had further decreased in group A, while reaching postnatal levels again in group B. Postnatal carnitine levels are higher in very immature preterm infants compared with full-term infants, but become lower on day 28. However, the commonly used metabolite ratios should still allow the detection of inborn errors of metabolism. Determination of acylcarnitines by means of tandem mass spectrometry (MS/MS) is of increasing importance in the screening for disorders of inborn errors of metabolism (1-3). Metabolic screening is also applied to preterm infants, although normal ranges are not yet established. However, carnitine levels in cord blood measured by MS/MS differed between term and preterm infants (4). Another study reported increased postnatal plasma and RBC carnitine levels in preterm infants (5). No sufficient data about dried blood spot acylcarnitine profiles in premature neonates are available so far. Especially in very immature preterm infants, initiation of enteral feeding is often delayed, and total or partial parenteral nutrition is needed for a considerable period of time. Several studies have shown that carnitine levels decrease with total parenteral nutrition in term (6) as well as in preterm infants (7). Therefore, screening for inborn errors of metabolism of preterm infants, e.g. in Germany, is repeated after 2-4 wk, when oral feeding is well established (8). In this study, we investigated carnitine levels longitudinally in premature neonates by means of MS/ MS, including very immature infants (gestational age from 22 wk) during the first 4 weeks of postnatal life to test the need of individual normal ranges for metabolic screening.
METHODSSolvents, reagents and internal standards. High-purity grade methanol was obtained from Merck (Darmstadt, Germany). Butanolic HCl (3 M) was prepared from high purity butanol (Merck) and HCl-gas. Stable isotopes used as internal standards were obtained from Neo Gen Scre...